Nanne De Boer

Nanne De Boer


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Gastroenterology
Verified
Journal Article
Open access
PDF file
NCNaga Chalasani
Naga Chalasani
HBHerbert L. Bonkovsky
Herbert L. Bonkovsky
RFRobert Fontana
Robert Fontana
WLWilliam Lee
William Lee
ASAndrew Stolz
Andrew Stolz
RRRebekah Van Raaphorst
Rebekah Van Raaphorst
Background & Aims The Drug-Induced Liver Injury Network is conducting a prospective study of patients with DILI in the United States. We present characteristics and subgroup analyses from the first 1257 patients enrolled in the study. Methods In an observational longitudinal study, we began collecting data on eligible individuals with suspected DILI in 2004, following them for 6 months or longer. Subjects were evaluated systematically for other etiologies, causes, and severity of DILI. Results Among 1257 enrolled subjects with suspected DILI, the causality was assessed in 1091 patients, and 899 were considered to have definite, highly likely, or probable DILI. Ten percent of patients died or underwent liver transplantation, and 17% had chronic liver injury. In the 89 patients (10%) with pre-existing liver disease, DILI appeared to be more severe than in those without (difference not statistically significant; P = .09) and mortality was significantly higher (16% vs 5.2%; P < .001). Azithromycin was the implicated agent in a higher proportion of patients with pre-existing liver disease compared with those without liver disease (6.7% vs 1.5%; P = .006). Forty-one cases with latency ≤7 days were caused predominantly by antimicrobial agents (71%). Two most common causes for 60 DILI cases with latency >365 days were nitrofurantoin (25%) or minocycline (17%). There were no differences in outcomes of patients with short vs long latency of DILI. Compared with individuals younger than 65 years, individuals 65 years or older (n = 149) were more likely to have cholestatic injury, although mortality and rate of liver transplantation did not differ. Nine patients (1%) had concomitant severe skin reactions; implicated agents were lamotrigine, azithromycin, carbamazepine, moxifloxacin, cephalexin, diclofenac, and nitrofurantoin. Four of these patients died. Conclusions Mortality from DILI is significantly higher in individuals with pre-existing liver disease or concomitant severe skin reactions compared with patients without. Additional studies are needed to confirm the association between azithromycin and increased DILI in patients with chronic liver disease. Older age and short or long latencies are not associated with DILI mortality.

1 November 2017 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
CPCyriel Y Ponsioen
Cyriel Y Ponsioen
EGE Joline de Groof
E Joline de Groof
EEEmma J Eshuis
Emma J Eshuis
TGTjibbe J Gardenbroek
Tjibbe J Gardenbroek
PBPatrick M M Bossuyt
Patrick M M Bossuyt
PMPritesh Morar
Pritesh Morar

11 November 2018 in Hepatology
Verified
Journal Article
Closed access
PDF file
YMYanling Ma
Yanling Ma
OBOlga V. Belyaeva
Olga V. Belyaeva
PBPhilip M. Brown
Philip M. Brown
KFKoji Fujita
Koji Fujita
KVKatherine Valles
Katherine Valles
TCThe Nash Crn
The Nash Crn

1 August 2014 in Gastroenterology
Verified
Journal Article
Open access
PDF file
NBNanne De Boer
Nanne De Boer
NGNicole M.F. van Gerven
Nicole M.F. van Gerven
AZAntonie Zwiers
Antonie Zwiers
BVBart J. Verwer
Bart J. Verwer
BHBart van Hoek
Bart van Hoek
GBGerd Bouma
Gerd Bouma
Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease of unknown etiology. We used a genome-wide approach to identify genetic variants that predispose individuals to AIH. We performed a genome-wide association study of 649 adults in The Netherlands with AIH type 1 and 13,436 controls. Initial associations were further analyzed in an independent replication panel comprising 451 patients with AIH type 1 in Germany and 4103 controls. We also performed an association analysis in the discovery cohort using imputed genotypes of the major histocompatibility complex region. We associated AIH with a variant in the major histocompatibility complex region at rs2187668 (P = 1.5 × 10−78). Analysis of this variant in the discovery cohort identified HLA-DRB1*0301 (P = 5.3 × 10−49) as a primary susceptibility genotype and HLA-DRB1*0401 (P = 2.8 × 10−18) as a secondary susceptibility genotype. We also associated AIH with variants of SH2B3 (rs3184504, 12q24; P = 7.7 × 10−8) and CARD10 (rs6000782, 22q13.1; P = 3.0 × 10−6). In addition, strong inflation of association signal was found with single-nucleotide polymorphisms associated with other immune-mediated diseases, including primary sclerosing cholangitis and primary biliary cirrhosis, but not with single-nucleotide polymorphisms associated with other genetic traits. In a genome-wide association study, we associated AIH type 1 with variants in the major histocompatibility complex region, and identified variants of SH2B3and CARD10 as likely risk factors. These findings support a complex genetic basis for AIH pathogenesis and indicate that part of the genetic susceptibility overlaps with that for other immune-mediated liver diseases.

1 September 2010 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
BJB. Jharap
B. Jharap
MSM. L. Seinen
M. L. Seinen
NBNanne De Boer
Nanne De Boer
JGJ. R. van Ginkel
J. R. van Ginkel
RLR. K. Linskens
R. K. Linskens
ABA. A. van Bodegraven
A. A. van Bodegraven
Background. Thiopurines have proven efficacy in long-term maintenance therapy of inflammatory bowel disease (IBD). Limited data are available with regard to fac

1 January 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NBNanne De Boer
Nanne De Boer
AKAndrzej S. Kosinski
Andrzej S. Kosinski
TUThomas J. Urban
Thomas J. Urban
ZZZhen Zhao
Zhen Zhao
NLNanye Long
Nanye Long
JHJay H. Hoofnagle
Jay H. Hoofnagle